Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX

NCT04703101 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT04703101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04703101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 1
Overall status
Recruiting
Start date
February 11, 2021
Completion date
October 15, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal carcinoma, rectal adenocarcinoma, stage ii rectal cancer ajcc v8, stage iia rectal cancer ajcc v8, stage iib rectal cancer ajcc v8, stage iic rectal cancer ajcc v8, stage iii rectal cancer ajcc v8, stage iiia rectal cancer ajcc v8, stage iiib rectal cancer ajcc v8, stage iiic rectal cancer ajcc v8